Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue (scientific article published on March 2006)

Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2

Q24291576

Sulfotransferases in the bioactivation of xenobiotics

Q28142541

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

Q28248709

cDNA cloning and expression of a new form of human aryl sulfotransferase

Q28283910

Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase

Q28303088

Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity

Q28575044

Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.

Q34124398

Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes

Q34283910

Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis

Q35349506

Pharmacogenetics of soluble sulfotransferases (SULTs)

Q35576913

Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal

Q40134033

Stable expression of rat sulfotransferase 1B1 in V79 cells: activation of benzylic alcohols to mutagens

Q40691748

Human phenol sulfotransferases hP-PST and hM-PST activate propane 2-nitronate to a genotoxicant

Q40902586

Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture

Q40996648

Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations

Q41464235

Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds

Q41734687

Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases

Q41753911

Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines

Q42542949

Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype

Q42665811

Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?

Q43623089

Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation

Q43715479

Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines

Q44030082

Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium.

Q44237759

Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues

Q44440235

Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes

Q44732796

Mutagenicity of aristolochic acids (I, II) and aristolic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes

Q50167755

Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives

Q50197007

Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium

Q50208536

Revised methods for the Salmonella mutagenicity test

Q50211560

Aristolochic acid is a direct mutagen in Salmonella typhimurium

Q50213217

Effect of diallyl sulfide on aristolochic acid-induced forestomach carcinogenesis in rats.

Q53481804

Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy)

Q55067470

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

1090-1097

P577

publication date

2006-03-01

P1433

published in

International Journal of Cancer

Q332492

P1476

title

Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue

P478

volume

118

Reverse relations

cites work (P2860)

Q33422844	13C-NMR data of diterpenes isolated from Aristolochia Species
Q89682425	Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
Q28079308	Balkan endemic nephropathy: an update on its aetiology
Q92368416	Bioactivation mechanisms of N-hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
Q36456392	Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study
Q34009989	Bioactivation of the human carcinogen aristolochic acid
Q46595257	Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid
Q36944066	Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk.
Q34561490	Characterization of the basal angiosperm Aristolochia fimbriata: a potential experimental system for genetic studies.
Q34359592	Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers
Q30520640	Contributions of human enzymes in carcinogen metabolism
Q33861885	Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse
Q47096788	DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
Q64898541	Developmental Expression of the Cytosolic Sulfotransferases in Human Liver.
Q38846241	Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening
Q38199198	Extrahepatic metabolism at the body's internal-external interfaces.
Q35057152	Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse
Q39844556	Human cytochrome P450 2E1 and sulfotransferase 1A1 coexpressed in Chinese hamster V79 cells enhance spontaneous mutagenesis
Q46248579	Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Q42791267	Identification and localization of soluble sulfotransferases in the human gastrointestinal tract.
Q41841343	Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid
Q42157886	Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
Q34500763	In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations.
Q26999077	Mechanisms of chemical carcinogenesis in the kidneys
Q28390347	Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches
Q38888279	Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels.
Q37031410	Modified Ames test using a strain expressing human sulfotransferase 1C2 to assess the mutagenicity of methyleugenol
Q24294352	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples
Q24297618	SULT1C3, an orphan sequence of the human genome, encodes an enzyme activating various promutagens
Q38740869	Structure, function and carcinogenicity of metabolites of methylated and non-methylated polycyclic aromatic hydrocarbons: a comprehensive review
Q42721088	Study of 5-hydroxymethylfurfural and its metabolite 5-sulfooxymethylfurfural on induction of colonic aberrant crypt foci in wild-type mice and transgenic mice expressing human sulfotransferases 1A1 and 1A2.
Q37074055	Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells
Q39121046	Sulfotransferase-independent genotoxicity of illudin S and its acylfulvene derivatives in bacterial and mammalian cells.
Q65001396	Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms.
Q42704738	The effect of knockout of sulfotransferases 1a1 and 1d1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models
Q27675561	The gate that governs sulfotransferase selectivity
Q61775759	The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases
Q49968489	Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of human sulfotransferases in the bioactivation of nitro- and aminotoluenes.
Q35155823	«Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins